250 participants
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-01
- Start Date:
- 2022-12-28
- Completion:
- 2030-03-31
Conditions
- Breast Cancer
Interventions
- DRUG
No Results Yet